Brought to you by Fresenius Kabi
Healthcare providers and patients can expect the same efficacy and safety from a biosimilar as from the…
Brought to you by Puma Biotechnology, Inc.
Looking for additional support tools for your patients taking NERLYNX® (neratinib)? The…
In ER+/HER2- metastatic breast cancer (mBC)
COULD ADVANCEMENTS IN ENDOCRINE…
Brought to you by Janssen Oncology
Subcutaneous Treatment for Multiple Myeloma
Janssen Oncology
April 27, 2021…
Brought to you by Research To Practice
Join Dr Neil Love and 29 invited clinical investigators for the continuation of this unique 11-…
Brought to you by Physicians' Education Resource®, LLC
Although multiple myeloma (MM) remains incurable, the past 15 years have yielded…
Brought to you by BD
In today’s demanding, fast-paced hospitals, clinicians can benefit from any added efficiencies, especially with…
Brought to you by Advanced Accelerator Applications
Advanced Accelerator Applications (AAA) is an innovative medicines company focused…
Brought to you by GSK
Please join our BLENREP belantamab mafodotin-blmf presentation on Thursday, April 29th at 3:00 PM.